Iuri Golubev, MD
Ophthalmology · Albuquerque, NMNPI 1861633265
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,163 of the $6,966 with a category attached, or 74.1%. 16 manufacturers reported payments, led by Genentech, Inc. at 33.3% of the total.
Across 79 payments — averaging $88.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$2K
- Alcon$2K
- Genentech USA, Inc.$914
- AbbVie$427
- Apellis Pharmaceuticals, Inc.$179
- Dutch Ophthalmic, USA$174
- plus $936 from 10 others
Across 3 payments — averaging $18,472 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$55K
What the payments were for
- Consulting fees$1,76025%
- Food & beverage$5,16374%
- Education$431%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 8 | $2,321 |
| Alcon | 20 | $2,017 |
| Genentech USA, Inc. | 15 | $914 |
| AbbVie(2 entities) | 9 | $427 |
| Apellis Pharmaceuticals, Inc. | 4 | $179 |
| Dutch Ophthalmic, USA | 2 | $174 |
| Regeneron Healthcare Solutions, Inc. | 6 | $161 |
| Regeneron | 3 | $137 |
| Biogen | 3 | $137 |
| Harrow Eye, LLC | 1 | $125 |
| F. Hoffmann-la Roche AG | 1 | $112 |
| Alimera Sciences, Inc. | 2 | $102 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $71 |
| AstraZeneca | 1 | $43 |
| Novartis | 2 | $24 |
| Astellas Pharma US Inc | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lucentis$1,907
- Constellation$1,205
- VABYSMO$665
- SUSVIMO$403
- NGENUITY$281
- Unity$238
- EVA, combined machine$143
- TISSUEBLUE$143
- OZURDEX$129
- DURYSTA$125
- Clareon$124
- Syfovre$109
How this compares
$6,966 in reported general payments places this provider in the 85th percentile of 81 ophthalmology providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 200 | $6,308 |
| Brimonidine Tartrate | 39 | $1,845 |
| Ofloxacin | 96 | $1,507 |
| Difluprednate | 16 | $1,410 |
| Dorzolamide Hcl | 61 | $1,238 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 72 | $1,205 |
| Atropine Sulfate | 16 | $843 |
| Latanoprost | 55 | $767 |
| Timolol Maleate | 18 | $323 |
| Prednisone | 29 | $311 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 15 | $113 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Albuquerque
- Robert MelendezAlbuquerque$349K
- John PitcherAlbuquerque$307K
- Christopher RoybalAlbuquerque$51K
- Stephen ColemanAlbuquerque$12K
- Rachel DavisAlbuquerque$10K
- Ian ThompsonAlbuquerque$10K
- Paul SanchezAlbuquerque$8K
- Thomas GilletteAlbuquerque$6K
- Kenneth DownesAlbuquerque$5K
- Arup DasAlbuquerque$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.